0001214659-20-010294.txt : 20201209 0001214659-20-010294.hdr.sgml : 20201209 20201209171112 ACCESSION NUMBER: 0001214659-20-010294 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201207 FILED AS OF DATE: 20201209 DATE AS OF CHANGE: 20201209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CRANDELL KEITH CENTRAL INDEX KEY: 0001219039 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 201378537 MAIL ADDRESS: STREET 1: 8755 W. HIGGINS ROAD STREET 2: SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-50520.xml PRIMARY DOCUMENT X0306 4 2020-12-07 0001581280 Twist Bioscience Corp TWST 0001219039 CRANDELL KEITH 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 true false false false Common Stock 2020-08-18 4 J false 685613 0 D 1721809 I By Arch Venture Fund VII, L.P. Common Stock 2020-08-18 4 J false 34845 0 A 34845 I By Keith L.Crandall Trust Common Stock 2020-08-18 4 J false 248083 0 D 706063 I By ARCH Venture Fund VIII Overage, L.P. Common Stock 2020-08-18 4 J false 3 0 A 34848 I By Keith L.Crandall Trust Common Stock 2020-09-02 4 J false 497032 0 D 1224777 I By Arch Venture Fund VII, L.P. Common Stock 2020-09-02 4 J false 25261 0 A 60109 I By Keith L.Crandall Trust Common Stock 2020-09-02 4 J false 220641 0 D 485422 I By ARCH Venture Fund VIII Overage, L.P. Common Stock 2020-09-02 4 J false 3 0 A 60112 I By Keith L.Crandall Trust Common Stock 2020-09-15 4 J false 444231 0 D 780546 I By Arch Venture Fund VII, L.P. Common Stock 2020-09-15 4 J false 22578 0 A 82690 I By Keith L.Crandall Trust Common Stock 2020-09-15 4 J false 176030 0 D 309392 I By ARCH Venture Fund VIII Overage, L.P. Common Stock 2020-09-15 4 J false 2 0 A 82692 I By Keith L.Crandall Trust Common Stock 2020-12-07 4 S false 53712 103.40 D 726834 I By Arch Venture Fund VII, L.P. Common Stock 2020-12-07 4 S false 21288 103.40 D 288104 I By ARCH Venture Fund VIII Overage, L.P. Common Stock 1412 D Pro-rata distribution of Common Stock held by a limited partnership to its partners for no consideration. The shares are directly held by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein. The shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). The sole general partner of ARCH Overage is ARCH Venture Partners VIII, LLC ("AVP GPLLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Overage. AVP GPLLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Change in form of ownership of shares previously reported as beneficially owned by the reporting person. /s/ Mark Daniels, as Attorney-in-Fact for Keith Crandell 2020-12-09